REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

Thu 16:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260604:nRSD0904Ha&default-theme=true

RNS Number : 0904H  Smith & Nephew Plc  04 June 2026

 

SMITH & NEPHEW PLC

 

4 June 2026

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

This announcement is made in accordance with the UK Market Abuse Regulation
(Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the
European Union (Withdrawal) Act 2018).

 

Smith & Nephew plc (the "Company") received notification of the following
transactions as detailed below.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc SPON ADR American Depositary Shares (ADS)
 Identification code                                          ISIN: US83175M2052
 Nature of the transaction                                    Director and PDMRs are participants of the Company's Employee Stock Purchase
                                                              Plan, which purchased American Depository Shares through the Company's
                                                              Dividend Re-Investment Plan following the 2025 final dividend payment on 27
                                                              May 2026.
 Date of Transaction                                          2026-06-03
 Place of Transaction                                         New York Stock Exchange

 

 Name                                               Director / PDMR  Price ($)  Volume    Aggregated information
 Deepak Nath                                        Director         29.8328    52.17441  N/A Single Transaction

 (Chief Executive Officer)
 Mizanu Kebede                                      PDMR             29.8328    22.19261  N/A Single Transaction

 (Chief Quality & Regulatory Affairs Officer)
 Paul Connolly                                      PDMR             29.8328    52.00997  N/A Single Transaction

 (President, Global Operations)
 Scott Schaffner                                    PDMR             29.8328    57.56604  N/A Single Transaction

 (President, Sports Medicine)

 

 

 

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFESRAISIIR



            Copyright 2019 Regulatory News Service, all rights reserved